PHARMACOLOGIC INHIBITION OF LIPOGENESIS SUPPRESSES AR AND ITS SPLICE VARIANTS TO INHIBIT PROGRESSION OF CASTRATION-RESISTANT PROSTATE CANCER
$2,982,816FY2017Department of the ArmyDOD
Dana-Farber Cancer Institute, Inc.
Dana-Farber Cancer Institute, Inc.